Problem statement: Answer the multiple choice question.
Query: Which compound exhibits a -1.345\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a) CCOc1ccc(OCC)c(NC(=O)CSc2nc3cccnc3n2C)c1
b) CC1=C(C(=O)OCc2ccccc2)N2C(=O)[C@@H](NC(=O)COc3ccccc3)[C@H]2SC1
c) CCc1ccc(NC(=O)CSc2nc3[nH]ncc3c(=O)[nH]2)cc1
d) Cc1cc(C)cc(NC(=O)C2CCN(C(=O)c3cccs3)CC2)c1
e) C/C(CC(=O)Nc1ccc2c(c1)OCO2)=N\NC(=O)c1ccc(N)cc1
Answer: a. CCOc1ccc(OCC)c(NC(=O)CSc2nc3cccnc3n2C)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOc1ccc(OCC)c(NC(=O)CSc2nc3cccnc3n2C)c1
CCOc1ccc(OCC)c(NC(=O)CSc2nc3cccnc3n2C)c1
N-(2,5-diethoxyphenyl)-2-(3-methylimidazo[4,5-b]pyridin-2-yl)sulfanylacetamide